SINOVAC BIOTECH LTD

# Sinovac Biotech Ltd (SVA)

Sinovac Biotech is a biopharmaceutical company that develops and manufactures vaccines for infectious diseases. The company focuses on research, development, production, and distribution of vaccines targeting viral and bacterial pathogens. Its product portfolio includes vaccines for diseases such as polio, hepatitis A, hepatitis B, dengue fever, and Japanese encephalitis, along with pandemic influenza vaccines. The company also produces varicella and measles-related vaccines for the Asian and emerging markets.

The company generates revenue primarily through vaccine sales to government immunization programs, healthcare institutions, and private distributors across multiple regions. Sinovac maintains manufacturing facilities and research capabilities in China and has established distribution networks in Asia, Latin America, and other emerging markets. The company's operations span vaccine development from preclinical research through clinical trials to large-scale manufacturing and commercialization.

Sinovac is incorporated in Antigua and Barbuda and listed on the Nasdaq. The company operates across multiple geographic markets with a focus on immunization needs in developing and middle-income countries where vaccine demand remains substantial.